Journals / Erciyes Tıp Dergisi / 2007 / Cilt: 29 - Sayı: 5

Asemptomatik bir hastada invaziv duktal meme karsinomunun uterus metastazinin sitolojik inceleme ile taninmasi: Bir olgu sunumu

Uterine metastasis of invasive ductal breast carcinoma diagnosed by cytological examination in an asymptomatic patient: An unusual case report

Pages
403–406
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Even if there are not any gynecologic symptoms and findings in a patient who has breast cancer history, a detail systematic pelvic examination of these patients must be done yearly.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Uterine metastasis of malignant tumors occurs very rarely.
📊
Key Findings & Data:Despite abnormal uterine bleeding is the most common symptom of metastatic uterine disease, less than 5% of patients may have not any gynecologic symptoms and diagnosis is made usually following abnormal cervical cytology.
💡
Conclusion & Impact:Even if there are not any gynecologic symptoms and findings in a patient who has breast cancer history, a detail systematic pelvic examination of these patients must be done yearly.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Uterine metastasis of malignant tumors occurs very rarely. Despite abnormal uterine bleeding is the most common symptom of metastatic uterine disease, less than 5% of patients may have not any gynecologic symptoms and diagnosis is made usually following abnormal cervical cytology. Here we present a case of uterine metastasis of invasive ductal breast carcinoma that was diagnosed by cervical cytological examination during breast cancer follow up. Even if there are not any gynecologic symptoms and findings in a patient who has breast cancer history, a detail systematic pelvic examination of these patients must be done yearly.

Özet

Malign tümörlerin uterusa metastazlan son derecede nadirdir. Uterusun metastatik tümörlerinde anormal uterin kanama en sık görülen semptom olmasma ragmen hastalann %5'inden azmda herhangi bir jinekolojik semptom bulunmaz ve tanı çoğunlukla anormal servikal sitolojinin değerlendirilmesiyle konulur. Burada takipte olan meme kanserli bir hastada servikal sitolojik inceleme ile tespit edilen invaziv duktal meme karsinomunun uterusa metastası sunulmuştur. Meme kanseri hikayesi olan bir hastada herhangi bir jinekolojik semptom ve bulgu olmasa bile bu hastalann detayh bir sistemik pelvik muayenesi yıllık olarak yapilmalıdir

🔖

Cite This Article

ÖZÇELİK, B., SERİN, İ. S., TÜRKYILMAZ, Ç., SOYUER, I. (2022). Asemptomatik bir hastada invaziv duktal meme karsinomunun uterus metastazinin sitolojik inceleme ile taninmasi: Bir olgu sunumu. Erciyes Tıp Dergisi, Cilt: 29 - Sayı: 5, 403–406. https://ajindex.com/articles/502718

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kumar NB, Hart WR. Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer 1982:50:2163–69 2. Afriat R, Lenain H, Vuagnat C, Michenet P, Luthier F, Maitre F, Grossetti D. Metastasis of breast cancer to a uterine leiomyoma. J Gynecol Obstet Biol Reprod 1993; 22: 243–4. 3. Le Bouedec G, Kauffmann P, De Latour M, Fondrinier E, Cure H, Dauplat J. Uterine metastases of breast cancer: report of eight cases. J Gynecol Obstet Biol Reprod 1991; 20: 349-54. 4. Piura B, Yanaı I, Rabinovich A, Zalmanov S, Goldstein J. Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix, and vagina in a breast cancer patient on tamoxifen therapy. Eur. J. Obstet Gynecol. Reprod. Biol 1999; 83: 57–61. 5. Guidos BJ, Selvaggi SM. Detection of endometrial adenocarcinoma with the ThinPrep Pap tests. Diagn Cytopathol. 2000; 23: 260–5. 6. Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inhorn SL. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol 1997; 90: 278–84. 7. Monteagudo C, Merino Mj, LaPorte N, Neumann RD. Value of gross cystic disease fluid protein–15 in distinguishing metastatic breast carcinoma among poorly differentiated neoplasms involving the ovary. Hum Pathol 1992; 22: 368– 72. 8.Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC, Kiang DT. Gross cystic disease fluid protein–15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol 1989; 20: 281-7. 9.Mazur MT, Hsueh S, Gersell DJ. Metastases to the female genital tract: analysis of 325 cases. Cancer 1984;53: 1978– 84.